No Data
No Data
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating
Centessa Pharmaceuticals (CNTA) has an average buy rating and price target range of $11 to $20, according to analysts polled by Capital IQ. Price: 9.14, Change: +0.28, Percent Change: +3.10
Centessa Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 11.56% Morgan Stanley $8 → $11 Maintains Equal-Weight 04/01/2024 52.13% BMO Capital $15 → $15 M
Express News | Centessa Pharmaceuticals, Inc : Morgan Stanley Raises Target Price to $11.00 From $8.00
Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Hold Rating, Raises Target Price to $11
Morgan Stanley analyst Jeffrey Hung maintains $Centessa Pharmaceuticals(CNTA.US)$ with a hold rating, and adjusts the target price from $8 to $11.According to TipRanks data, the analyst has a success
Centessa Pharmaceuticals Plc's (NASDAQ:CNTA) Institutional Investors Lost 12% Over the Past Week but Have Profited From Longer-term Gains
Key Insights Significantly high institutional ownership implies Centessa Pharmaceuticals' stock price is sensitive to their trading actions A total of 8 investors have a majority stake in the compan